Lexicon Pharmaceuticals Inc (LXRX)
1.65
+0.10
(+6.80%)
USD |
NASDAQ |
May 01, 16:00
1.68
+0.03
(+1.82%)
After-Hours: 19:10
Lexicon Pharmaceuticals Cash from Financing (Quarterly): -0.001M for Dec. 31, 2023
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -0.001M |
| September 30, 2023 | -0.21M |
| June 30, 2023 | 189.00M |
| March 31, 2023 | -0.824M |
| December 31, 2022 | 24.91M |
| September 30, 2022 | 94.02M |
| June 30, 2022 | 0.00 |
| March 31, 2022 | 23.28M |
| December 31, 2021 | -11.32M |
| September 30, 2021 | 19.78M |
| June 30, 2021 | -0.023M |
| March 31, 2021 | 14.27M |
| December 31, 2020 | 64.15M |
| September 30, 2020 | -210.12M |
| June 30, 2020 | -0.425M |
| March 31, 2020 | -1.244M |
| December 31, 2019 | -0.322M |
| September 30, 2019 | -0.32M |
| June 30, 2019 | -0.322M |
| March 31, 2019 | -1.262M |
| December 31, 2018 | -0.139M |
| September 30, 2018 | -0.356M |
| June 30, 2018 | -0.221M |
| March 31, 2018 | -1.528M |
| December 31, 2017 | 147.84M |
| Date | Value |
|---|---|
| September 30, 2017 | -0.498M |
| June 30, 2017 | 3.69M |
| March 31, 2017 | -1.104M |
| December 31, 2016 | 0.16M |
| September 30, 2016 | 1.684M |
| June 30, 2016 | 0.071M |
| March 31, 2016 | -0.928M |
| December 31, 2015 | -0.471M |
| September 30, 2015 | -0.353M |
| June 30, 2015 | -0.378M |
| March 31, 2015 | -0.83M |
| December 31, 2014 | 285.66M |
| September 30, 2014 | -0.266M |
| June 30, 2014 | -0.36M |
| March 31, 2014 | -1.231M |
| December 31, 2013 | -0.112M |
| September 30, 2013 | 0.022M |
| June 30, 2013 | -0.288M |
| March 31, 2013 | -1.011M |
| December 31, 2012 | 36.82M |
| September 30, 2012 | 0.407M |
| June 30, 2012 | -0.129M |
| March 31, 2012 | -0.722M |
| December 31, 2011 | 160.25M |
| September 30, 2011 | -0.328M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-210.12M
Minimum
Sep 2020
189.00M
Maximum
Jun 2023
10.75M
Average
-0.023M
Median
Jun 2021
Cash from Financing (Quarterly) Benchmarks
| Windtree Therapeutics Inc | 0.521M |
| Novavax Inc | 100.39M |
| AIM ImmunoTech Inc | 0.147M |
| Protalix BioTherapeutics Inc | 0.00 |
| Armata Pharmaceuticals Inc | -0.043M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -50.55M |
| Cash from Investing (Quarterly) | 51.90M |
| Free Cash Flow | -162.37M |
| Free Cash Flow Per Share (Quarterly) | -0.2062 |
| Free Cash Flow to Equity (Quarterly) | -50.79M |
| Free Cash Flow Yield | -44.53% |